search icon
bcax-img

Bicara Therapeutics Inc. Common Stock, Common Stock

BCAX

NMQ

$9.44

-$0.02

(-0.21%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$854.04M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.05M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.8 L
$28.09 H
$9.44

About Bicara Therapeutics Inc. Common Stock, Common Stock

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameBCAXSectorS&P500
1-Week Return-39.72%0.71%0.79%
1-Month Return-36.56%-5.6%6.04%
3-Month Return-29.02%-11.72%-1.11%
6-Month Return-54.59%-10.81%-2.39%
1-Year Return-47.56%-7.12%11.69%

Financials

Dec '22Dec '23Dec '24
Total Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses37.66M39.89M82.39M[{"date":"2022-12-31","value":45.71,"profit":true},{"date":"2023-12-31","value":48.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(37.66M)(39.89M)(82.39M)[{"date":"2022-12-31","value":-3765600000,"profit":false},{"date":"2023-12-31","value":-3988900000,"profit":false},{"date":"2024-12-31","value":-8238900000,"profit":false}]
Total Non-Operating Income/Expense(296.00K)(10.78M)29.16M[{"date":"2022-12-31","value":-1.02,"profit":false},{"date":"2023-12-31","value":-36.96,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(37.84M)(51.98M)(67.81M)[{"date":"2022-12-31","value":-3784400000,"profit":false},{"date":"2023-12-31","value":-5198000000,"profit":false},{"date":"2024-12-31","value":-6780800000,"profit":false}]
Income Taxes1.00K5.00K187.00K[{"date":"2022-12-31","value":0.53,"profit":true},{"date":"2023-12-31","value":2.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(37.84M)(51.98M)(68.00M)[{"date":"2022-12-31","value":-3784500000,"profit":false},{"date":"2023-12-31","value":-5198500000,"profit":false},{"date":"2024-12-31","value":-6799500000,"profit":false}]
Income From Continuous Operations(37.84M)(51.98M)(68.00M)[{"date":"2022-12-31","value":-3784500000,"profit":false},{"date":"2023-12-31","value":-5198500000,"profit":false},{"date":"2024-12-31","value":-6799500000,"profit":false}]
Income From Discontinued Operations---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(37.84M)(51.98M)(68.00M)[{"date":"2022-12-31","value":-3784500000,"profit":false},{"date":"2023-12-31","value":-5198500000,"profit":false},{"date":"2024-12-31","value":-6799500000,"profit":false}]
EPS (Diluted)--(0.71)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-70.63,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BCAX
Cash Ratio 24.17
Current Ratio 24.62

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BCAX
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BCAX
Debt Ratio Lower is generally better. Negative is bad. 0.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.96

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BCAX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.77
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Bicara Therapeutics Inc. Common Stock share price today?

Bicara Therapeutics Inc. Common Stock (BCAX) share price today is $9.44

Can Indians buy Bicara Therapeutics Inc. Common Stock shares?

Yes, Indians can buy shares of Bicara Therapeutics Inc. Common Stock (BCAX) on Vested. To buy Bicara Therapeutics Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BCAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bicara Therapeutics Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Bicara Therapeutics Inc. Common Stock (BCAX) via the Vested app. You can start investing in Bicara Therapeutics Inc. Common Stock (BCAX) with a minimum investment of $1.

How to invest in Bicara Therapeutics Inc. Common Stock shares from India?

You can invest in shares of Bicara Therapeutics Inc. Common Stock (BCAX) via Vested in three simple steps:

  • Click on Sign Up or Invest in BCAX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bicara Therapeutics Inc. Common Stock shares
What is Bicara Therapeutics Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Bicara Therapeutics Inc. Common Stock (BCAX) is $28.09. The 52-week low price of Bicara Therapeutics Inc. Common Stock (BCAX) is $7.8.

What is Bicara Therapeutics Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bicara Therapeutics Inc. Common Stock (BCAX) is 1.77

What is the Market Cap of Bicara Therapeutics Inc. Common Stock?

The market capitalization of Bicara Therapeutics Inc. Common Stock (BCAX) is $854.04M

What is Bicara Therapeutics Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Bicara Therapeutics Inc. Common Stock is BCAX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top